Stock Screener App

Frei -

Installieren

16.30

2.32% 0.37

after-market

Handel nachbörslich: 16.30

Olema Pharmaceuticals Inc (OLMA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	4.15% 45.88	47.86	34.87	36.77	37.62
Operating Income/Loss	4.15% -45.88	-47.86	-34.87	-36.77	-37.62
Nonoperating Income/Loss	10.29% 3.66	4.08	4.484	3.201	3.066
Income/Loss From Continuing Operations Before Tax	3.58% -42.22	-43.78	-30.39	-33.56	-34.55
Income/Loss From Continuing Operations After Tax	3.58% -42.22	-43.78	-30.39	-33.57	-34.55
Net Income/Loss	3.58% -42.22	-43.78	-30.39	-33.57	-34.55
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.27% 85.73	85.50	85.43	5.5494	57.26
Diluted Average Shares	0.27% 85.73	85.50	85.43	5.5494	57.26
Basic Earnings Per Share	3.92% -0.49	-0.51	-0.36	-0.40	-0.60
Diluted Earnings Per Share	3.92% -0.49	-0.51	-0.36	-0.40	-0.60
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$48.82

0.81%

MRNA

$52.84

4.26%

BNTX

$98.41

1.77%

RVMD

$147.01

7.86%

INSM

$153.40

1.50%

ONC

$310.00

1.43%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters